BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
Phase 1 study will evaluate safety and immunogenicity in Chinese participants to support potential regulatory approval pathway in ChinaTotal of […]